The UK Treasury declared on March 13, that HSBC had acquired the UK arm of SVB for only £1 ($1.21), as financial hubs around the world try to mitigate the effects of the lender's multibillion-dollar collapse.
Many Chinese companies, including those in the biotech industry, are trying to calm down worried investors. BeiGene, a Chinese firm that is renowned for its research on cancer treatment, announced almost 4% of its cash about $175 million is being frozen in SVB.